RecruitingNot Applicable

Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty

Turkey (Türkiye)100 participantsStarted 2026-03-16

Plain-language summary

This prospective, randomized, double-blind study evaluates the analgesic effectiveness of the ultrasound-guided Quadro-Iliac Plane (QIP) block in patients undergoing primary total hip arthroplasty. The QIP block is a recently described fascial plane block. Patients will be randomized to receive either a QIP block with local anesthetic or a sham block with saline. The primary outcome is 24-hour opioid consumption. Secondary outcomes include motor block, dermatomal sensory assessment, pain scores, rescue analgesic requirement, quality of recovery (QoR-15), and opioid-related side effects.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * American Society of Anesthesiologists (ASA) classification I-III * Age between 18 and 80 years * Patients scheduled for elective primary total hip arthroplasty Exclusion Criteria: * Refusal to participate in the study * Allergy to local anesthetics or opioids * Known or suspected coagulopathy * Infection at the injection site * History of previous hip surgery * Severe cardiovascular disease * Liver or kidney failure * Pregnancy, suspected pregnancy, or breastfeeding * Severe neurological or psychiatric disorder * Chronic opioid use

What they're measuring

Postoperative 24-Hour Morphine PCA Consumption

Timeframe: Postoperative 24 hours

Trial details

NCT IDNCT07410000

SponsorBursa City Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2027-02-15

Contact for this trial

Mursel Ekinci, Assoc prof,MD

+905067137596 drmurselekinci@gmail.com

View on ClinicalTrials.gov More Pain Management trials